Catalyst Wire Dossier Catalyst Wire Dossier

BGB-C354

· BeOne Medicines
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BGB-C354, covering 2026-04-06 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-Human Study of BGB-C354 Alone and in Combination With Tislelizumab in Participants With Advanced Solid Tumors [Phase 1]

See pricing